Cargando…

Selamectin Is the Avermectin with the Best Potential for Buruli Ulcer Treatment

A comprehensive analysis was done to evaluate the potential use of anti-parasitic macrocyclic lactones (including avermectins and milbemycins) for Buruli ulcer (BU) therapy. A panel containing nearly all macrocyclic lactones used in human or in veterinary medicine was analyzed for activity in vitro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Scherr, Nicole, Pluschke, Gerd, Thompson, Charles J., Ramón-García, Santiago
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4536011/ https://www.ncbi.nlm.nih.gov/pubmed/26270480 http://dx.doi.org/10.1371/journal.pntd.0003996

Ejemplares similares

Susceptibility to Mycobacterium ulcerans Disease (Buruli ulcer) Is Associated with IFNG and iNOS Gene Polymorphisms
por: Bibert, Stéphanie, et al.
Publicado: (2017)

Targeting the Mycobacterium ulcerans cytochrome bc(1):aa(3) for the treatment of Buruli ulcer
por: Scherr, Nicole, et al.
Publicado: (2018)

Identification of the Mycobacterium ulcerans Protein MUL_3720 as a Promising Target for the Development of a Diagnostic Test for Buruli Ulcer
por: Dreyer, Anita, et al.
Publicado: (2015)

Immunohistochemical Monitoring of Wound Healing in Antibiotic Treated Buruli Ulcer Patients
por: Andreoli, Arianna, et al.
Publicado: (2014)

Buruli ulcer: The Efficacy of Innate Immune Defense May Be a Key Determinant for the Outcome of Infection With Mycobacterium ulcerans
por: Röltgen, Katharina, et al.
Publicado: (2020)

Triple oral beta-lactam containing therapy for Buruli ulcer treatment shortening
por: Arenaz-Callao, María Pilar, et al.
Publicado: (2019)

Development of Highly Organized Lymphoid Structures in Buruli Ulcer Lesions after Treatment with Rifampicin and Streptomycin
por: Schütte, Daniela, et al.
Publicado: (2007)

On the origin of Mycobacterium ulcerans, the causative agent of Buruli ulcer
por: Doig, Kenneth D, et al.
Publicado: (2012)

Local Cellular Immune Responses and Pathogenesis of Buruli Ulcer Lesions in the Experimental Mycobacterium Ulcerans Pig Infection Model
por: Bolz, Miriam, et al.
Publicado: (2016)

Buruli Ulcer in Cameroon: The Development and Impact of the National Control Programme
por: Tabah, Earnest Njih, et al.
Publicado: (2016)

Mycobacterium ulcerans DNA in Bandicoot Excreta in Buruli Ulcer–Endemic Area, Northern Queensland, Australia
por: Röltgen, Katharina, et al.
Publicado: (2017)

Infiltrating leukocytes surround early Buruli ulcer lesions, but are unable to reach the mycolactone producing mycobacteria
por: Ruf, Marie-Thérèse, et al.
Publicado: (2017)

A Case of Cutaneous Tuberculosis in a Buruli Ulcer–Endemic Area
por: Bratschi, Martin W., et al.
Publicado: (2012)

Experimental Infection of the Pig with Mycobacterium ulcerans: A Novel Model for Studying the Pathogenesis of Buruli Ulcer Disease
por: Bolz, Miriam, et al.
Publicado: (2014)

Repurposing Avermectins and Milbemycins against Mycobacteroides abscessus and Other Nontuberculous Mycobacteria
por: Muñoz-Muñoz, Lara, et al.
Publicado: (2021)

Phase Change Material for Thermotherapy of Buruli Ulcer: A Prospective Observational Single Centre Proof-of-Principle Trial
por: Junghanss, Thomas, et al.
Publicado: (2009)

Spatial Distribution of Mycobacterium ulcerans in Buruli Ulcer Lesions: Implications for Laboratory Diagnosis
por: Ruf, Marie-Thérèse, et al.
Publicado: (2016)

Assessing and managing wounds of Buruli ulcer patients at the primary and secondary health care levels in Ghana
por: Addison, Naa Okaikor, et al.
Publicado: (2017)

Burden and Historical Trend of Buruli Ulcer Prevalence in Selected Communities along the Offin River of Ghana
por: Ampah, Kobina Assan, et al.
Publicado: (2016)

Buruli Ulcer (M. ulcerans Infection): New Insights, New Hope for Disease Control
por: Johnson, Paul D. R, et al.
Publicado: (2005)

Mycolactone-Dependent Depletion of Endothelial Cell Thrombomodulin Is Strongly Associated with Fibrin Deposition in Buruli Ulcer Lesions
por: Ogbechi, Joy, et al.
Publicado: (2015)

Buruli Ulcer, Nigeria
por: Chukwuekezie, Okechukwu, et al.
Publicado: (2007)

Etymologia: Buruli Ulcer
por: Henry, Ronnie
Publicado: (2020)

Etymologia: Buruli Ulcer
por: Korman, Tony M., et al.
Publicado: (2020)

Mycobacterium ulcerans Persistence at a Village Water Source of Buruli Ulcer Patients
por: Bratschi, Martin W., et al.
Publicado: (2014)

Correction: Buruli Ulcer (M. ulcerans Infection): New Insights, New Hope for Disease Control
por: Johnson, Paul D. R, et al.
Publicado: (2005)

Perceived water-related risk factors of Buruli ulcer in two villages of south-central Côte d’Ivoire
por: Leuenberger, Andrea, et al.
Publicado: (2022)

Secondary Bacterial Infections of Buruli Ulcer Lesions Before and After Chemotherapy with Streptomycin and Rifampicin
por: Yeboah-Manu, Dorothy, et al.
Publicado: (2013)

Secondary Buruli Ulcer Skin Lesions Emerging Several Months after Completion of Chemotherapy: Paradoxical Reaction or Evidence for Immune Protection?
por: Ruf, Marie-Thérèse, et al.
Publicado: (2011)

Complete Healing of a Laboratory-Confirmed Buruli Ulcer Lesion after Receiving Only Herbal Household Remedies
por: Andreoli, Arianna, et al.
Publicado: (2015)

Treatment of rabbit cheyletiellosis with selamectin or ivermectin: a retrospective case study
por: Mellgren, Marianne, et al.
Publicado: (2008)

Buruli Ulcer Recurrence, Benin
por: Debacker, Martine, et al.
Publicado: (2005)

Buruli Ulcer Distribution in Benin
por: Johnson, Roch Christian, et al.
Publicado: (2005)

Buruli Ulcer in Liberia, 2012
por: Kollie, Karsor, et al.
Publicado: (2014)

Socio-Environmental Factors Associated with the Risk of Contracting Buruli Ulcer in Tiassalé, South Côte d’Ivoire: A Case-Control Study
por: N’krumah, Raymond T. A. S., et al.
Publicado: (2016)

Locally Confined Clonal Complexes of Mycobacterium ulcerans in Two Buruli Ulcer Endemic Regions of Cameroon
por: Bolz, Miriam, et al.
Publicado: (2015)

Local Heat Application for the Treatment of Buruli Ulcer: Results of a Phase II Open Label Single Center Non Comparative Clinical Trial
por: Vogel, Moritz, et al.
Publicado: (2016)

Assessment and Treatment of Pain during Treatment of Buruli Ulcer
por: de Zeeuw, Janine, et al.
Publicado: (2015)

Histopathological Changes and Clinical Responses of Buruli Ulcer Plaque Lesions during Chemotherapy: A Role for Surgical Removal of Necrotic Tissue?
por: Ruf, Marie-Thérèse, et al.
Publicado: (2011)

The Veterinary Anti-Parasitic Selamectin Is a Novel Inhibitor of the Mycobacterium tuberculosis DprE1 Enzyme
por: Ezquerra-Aznárez, José Manuel, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_02c90it9n8h8ck734ferb64f2f